Assignee profile:

Dynogen Pharmaceuticals, Inc.

City:

Boston, Massachusetts

Country:

United States

Published Applications:

10

Last publication date:

2009-08-13

Patent Grants:

4

Last grant date:

2008-12-02

Top Inventors for applications by Dynogen Pharmaceuticals, Inc.

These are the the leading inventors for applications assigned to Dynogen Pharmaceuticals, Inc.:

Recent patent applications by Dynogen Pharmaceuticals, Inc.

Dynogen Pharmaceuticals, Inc. based in Boston, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2009-08-13
US20090203792A1
Human necessities

METHODS OF TREATING NON-PAINFUL BLADDER DISORDERS USING ALPHA2DELTA SUBUNIT CALCIUM CHANNEL MODULATORS

#2 | 2008-04-10
US20080085916A1
Human necessities

METHODS FOR TREATING LOWER URINARY TRACT DISORDERS USING ALPHA2DELTA SUBUNIT CALCIUM CHANNEL MODULATORS WITH SMOOTH MUSCLE MODULATORS

#3 | 2007-05-10
US20070105785A1
Human necessities

Methods of treating non-inflammatory gastrointestinal tract disorders using Cav2.2 subunit calcium channel modulators

#4 | 2006-10-19 ✅ Patent 7,459,430 granted on 2008-12-02
US20060234939A1
Human necessities

Methods of using ziconotide to treat overactive bladder

#5 | 2006-08-01 ✅ Patent 7,084,116 granted on 2006-08-01
US10796952
-

Methods for treating lower urinary tract disorders and the related disorders vulvodynia and vulvar vestibulitis using Ca2.2 subunit calcium channel modulators

#6 | 2005-10-27
US20050239890A1
Human necessities

Methods for decreasing detrusor muscle overactivity

#7 | 2005-09-15 ✅ Patent 7,041,704 granted on 2006-05-09
US20050203190A1
Human necessities

Methods of treating gastrointestinal tract disorders using sodium channel modulators

#8 | 2005-05-19
US20050107353A1
Human necessities

Methods of treating lower urinary tract disorders using losigamone

#9 | 2005-03-10
US20050054725A1
Human necessities

Methods of treating non-painful bladder disorders using alpha2delta subunit calcium channel modulators

#10 | 2005-02-03 ✅ Patent 7,125,848 granted on 2006-10-24
US20050026835A1
Human necessities

Methods of treating non-inflammatory gastrointestinal tract disorders using Cav2.2 subunit calcium channel modulators

AssigneeID:

251980 ⎘